Novartis | NOVN - Işletim Giderleri





Işletim Giderleri Değişiklik Tarih
AbbVie USD 10.52B 258M 2026-09
Alcon AG USD 2.78B 370M 2026-06
Almirall EUR 531.16M 13.76M 2026-06
Amgen USD 5.69B 6B 2026-09
AstraZeneca USD 11.55B 674M 2026-09
Autolus Therapeutics Ltd USD 85.73M 11.02M 2026-03
Bayer EUR 9.92B 121M 2026-09
Biogen USD 2.32B 663.6M 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Eli Lilly USD 10.52B 496M 2026-06
Fresenius EUR 5.23B 9M 2026-06
Fresenius Medical Care EUR 4.55B 229.7M 2026-09
Genmab DKK 748M 77M 2026-06
Gilead Sciences USD 13.04B 9.09B 2026-09
GlaxoSmithKline GBP 6.03B 227M 2026-09
GRIFOLS EUR 1.65B 101M 2026-09
Hikma Pharmaceutical USD 1.34B 702M 2025-12
J&J USD 18.93B 1.09B 2026-09
Lakefront Biotherapeutics EUR 55.62M 14.56M 2026-06
Lonza CHF 2.9B 184M 2025-06
Merck EUR 4.34B 249M 2026-06
Merck USD 10.75B 5.02B 2026-09
Novartis USD 9.88B 325M 2026-09
Novartis USD 13.19B 3.9B 2026-09
Novo Nordisk DKK 44.73B 7.52B 2026-06
Orion EUR 332.3M 12.7M 2026-09
Pfizer USD 89B 3.81B 2026-09
Philips EUR 3.75B 147M 2026-06
Recordati EUR 493.59M 11.28M 2026-06
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 10.51B 598M 2026-09
UCB EUR 2.96B 196M 2025-12